您的位置: 首页 > 2015年9月 第46卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

中青年男性膀胱过度活动症与Ⅲ型慢性前列腺炎的诊断重叠性研究

Overlap of diagnosis of overactive bladder and Ⅲ chronic prostatitis in young men

来源期刊: 广州医药 | 25-27 发布时间:2021-11-30 收稿时间:2025/11/13 16:41:19 阅读量:6
作者:
关键词:
膀胱过度活动症慢性前列腺炎诊断重叠
Overactive BladderChronic ProstatitisDiagnosisOverlap
DOI:
10.3969/j.issn.1000-8535.2015.05.008
收稿时间:
2015-07-02 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨OAB与CP/CPPS的症状及诊断的重叠情况,为临床诊疗提供参考。方法 151例中青年男性患者入选为研究对象,按OAB及CP/CPPS的定义及诊断标准将其分为OAB组、CP/CPPS组及OAB+CP/CPPS组,并对OAB+CP/CPPS组进行诊断性治疗对研究对象进行明确诊断;根据年龄分为:18~25岁组、26~35岁组和36~49岁组,比较各年龄组患者OAB及CP/CPPS的重叠情况;对各组患者的临床症状进行分析比较,了解其重叠情况。结果 在151例研究对象中,可诊断为OAB、CP/CPPS、OAB+CP/CPPS的分别有62例(41.06%)、32例(21.19%)、57例(37.75%),因此OAB与CP/CPPS的诊断重叠率为37.75%,明显大于CP/CPPS患者的诊断率;各年龄组间诊断重叠率无差异(P>0.05);症状的重叠方面,OAB+CP/CPPS组有尿急、尿频、夜尿症、急迫性尿失禁、尿不尽感、排尿困难、泌尿生殖系疼痛和或不适症状的分别为57例(100.00%)、50例(87.72%)、21例(36.84%)、2例(3.51%)、12例(21.05%)、2例(3.51%)、57例(100.00%),其中,尿急、尿频及泌尿生殖系疼痛或不适症状的重叠率最高;OAB+CP/CPPS组经诊断性治疗后诊断为OAB患者约61.40%,而CP/CPPS患者为38.60%。结论 OAB与CP/CPPS两者间有相当高的重叠率且远高于CP/CPPS的诊断率,在OAB与CP/CPPS两者诊断重叠的患者中为OAB的可能性更大。
Objective To explore symptoms and diagnosis of overlap between OAB and CP/CPPS, providing reference for clinical treatment. Methods 151 cases of young men were enrolled in the study. According to the definition and diagnostic criteria of OAB and CP/CPPS, we divided the study subjects into OAB group, CP/CPPS group and OAB+CP/CPPS group. And OAB+CP/CPPS group would get a two-week diagnostic treatment to study a clear diagnosis. We also divided the subjects into 18-25 age group, 26-35 year-old age group and 36-49 group according to the age, comparing the overlap of OAB and CP/CPPS in different age groups. The symptoms of the subjects in each group were analyzed to compare and study the overlap. Results Among these 151 cases, 62 cases (41.06%) can be diagnosed as OAB, 32 cases (21.19%) as CP/CPPS, 57 cases (37.75%) as OAB+CP/CPPS. Therefore, OAB and CP/CPPS diagnostic overlap was 37.75%, significantly higher than the diagnosis of CP/CPPS patients; no significant difference (P>0.05) among all age groups diagnostic overlap rate; overlapping terms of symptoms, OAB + CP/CPPS group urgency, urinary frequency, nocturia, urgency incontinence, urine not the flu, difficulty urinating, or genitourinary pain and discomfort were 57 cases (100.00%), 50 cases (87.72%), 21 cases (36.84%), 2 cases (3.51%), 12 cases (21.05%), 2 cases (3.51%), 57 patients (100.00%), which overlap ratio urgency, frequency, and genitourinary pain or discomfort was high; OAB+CP/CPPS group after diagnosis diagnostic treatment of OAB patients was about 61.40%, while CP/CPPS patients was 38.60%. Conclusion There is high overlap rate between OAB and CP/CPPS, which is much higher than the diagnostic rate of CP/CPPS. It is likely to have an OAB when a patient is diagnosed as OAB or CP/CPPS at the same time.
1、 Barry MJ, Link CL, McNaughton-Collins MF, et al. Boston Area Community Health (BACH) Investigators, Overlap of different urological symptom complexes in a racially and ethnically diverse, community-based population of men and women[J]. BJU Int,2008, 101(1):45-51. Barry MJ, Link CL, McNaughton-Collins MF, et al. Boston Area Community Health (BACH) Investigators, Overlap of different urological symptom complexes in a racially and ethnically diverse, community-based population of men and women[J]. BJU Int,2008, 101(1):45-51.
2、 Gratzke C, Bachmann A, De scaz eaud A, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms includingBenign Prostatic Obstruction[J]. Eur Urol,2015,67(6):1099-109. Gratzke C, Bachmann A, De scaz eaud A, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms includingBenign Prostatic Obstruction[J]. Eur Urol,2015,67(6):1099-109.
3、 Tripp DA, Nickel JC, et al. A survey of cannabis (marijuana) use and self-reported benefit in men with chronicprostatitis/chronic pelvic pain syndrome[J]. Can Urol Assoc J,2014,8(11-12):E901-905 Tripp DA, Nickel JC, et al. A survey of cannabis (marijuana) use and self-reported benefit in men with chronicprostatitis/chronic pelvic pain syndrome[J]. Can Urol Assoc J,2014,8(11-12):E901-905
4、 Rees J, Abrahams M, Doble A, et al. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline[J]. Prostatitis Expert Reference Group (PERG). BJU Int, 2015 Feb 24. doi: 10.1111/bju.13101. Rees J, Abrahams M, Doble A, et al. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline[J]. Prostatitis Expert Reference Group (PERG). BJU Int, 2015 Feb 24. doi: 10.1111/bju.13101.
5、 Homma Y, Kakizaki H, Yamaguchi O,et al. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score[J]. Urology, 2011, 77(1):60-64. Homma Y, Kakizaki H, Yamaguchi O,et al. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score[J]. Urology, 2011, 77(1):60-64.
6、 Nickel JC, Shoskes DA, Wagenlehner FME. Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): The studies, the evidence and the impact[J]. World J Urol.,2013(31):747-753. Nickel JC, Shoskes DA, Wagenlehner FME. Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): The studies, the evidence and the impact[J]. World J Urol.,2013(31):747-753.
7、 Irwin DE, Milsom I, Kopp Z, et al. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder[J]. Eur Urol,2009,56(1):14-20. Irwin DE, Milsom I, Kopp Z, et al. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder[J]. Eur Urol,2009,56(1):14-20.
8、 Bhavin N. Patel, Robert J. Overactive bladder and pain: management strategies[J]. Curr Urol Rep, 2010, 11(6):379-384. Bhavin N. Patel, Robert J. Overactive bladder and pain: management strategies[J]. Curr Urol Rep, 2010, 11(6):379-384.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录